On May 2, 2022, Dr. James I. Healy submitted his resignation as an independent member of the Ascendis Pharma A/S board of directors and as a member of the audit committee of the Board and the nominating and corporate governance committee of the Board, effective May 30, 2022. Dr. Healy's resignation was not due to any disagreement with the Company, the Board or the management of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
133.5 USD | +0.25% | -2.73% | +5.96% |
May. 10 | Paycom Software Insider Sold Shares Worth $503,551, According to a Recent SEC Filing | MT |
May. 06 | European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.96% | 7.62B | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- ASND Stock
- News Ascendis Pharma A/S
- Ascendis Pharma A/S Announces Resignation of James I. Healy as Independent Member of Board of Directors, Effective from May 30, 2022